全文获取类型
收费全文 | 2500篇 |
免费 | 174篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 99篇 |
儿科学 | 49篇 |
妇产科学 | 7篇 |
基础医学 | 442篇 |
口腔科学 | 81篇 |
临床医学 | 224篇 |
内科学 | 488篇 |
皮肤病学 | 53篇 |
神经病学 | 258篇 |
特种医学 | 186篇 |
外国民族医学 | 1篇 |
外科学 | 345篇 |
综合类 | 31篇 |
预防医学 | 162篇 |
眼科学 | 32篇 |
药学 | 116篇 |
中国医学 | 3篇 |
肿瘤学 | 103篇 |
出版年
2023年 | 17篇 |
2021年 | 42篇 |
2020年 | 28篇 |
2019年 | 36篇 |
2018年 | 42篇 |
2017年 | 37篇 |
2016年 | 52篇 |
2015年 | 50篇 |
2014年 | 79篇 |
2013年 | 107篇 |
2012年 | 120篇 |
2011年 | 139篇 |
2010年 | 78篇 |
2009年 | 65篇 |
2008年 | 116篇 |
2007年 | 116篇 |
2006年 | 112篇 |
2005年 | 94篇 |
2004年 | 94篇 |
2003年 | 89篇 |
2002年 | 100篇 |
2001年 | 76篇 |
2000年 | 65篇 |
1999年 | 55篇 |
1998年 | 38篇 |
1997年 | 38篇 |
1996年 | 36篇 |
1995年 | 30篇 |
1994年 | 39篇 |
1993年 | 23篇 |
1992年 | 55篇 |
1991年 | 42篇 |
1990年 | 50篇 |
1989年 | 46篇 |
1988年 | 33篇 |
1987年 | 18篇 |
1986年 | 29篇 |
1985年 | 27篇 |
1984年 | 32篇 |
1983年 | 16篇 |
1982年 | 20篇 |
1981年 | 16篇 |
1979年 | 29篇 |
1978年 | 20篇 |
1977年 | 18篇 |
1976年 | 25篇 |
1975年 | 16篇 |
1973年 | 19篇 |
1972年 | 22篇 |
1971年 | 20篇 |
排序方式: 共有2680条查询结果,搜索用时 15 毫秒
61.
Marieke de Vries Angela Fagerlin Holly O. Witteman Laura D. Scherer 《Patient education and counseling》2013
Objective
To review the strengths and weaknesses of deliberative and intuitive processes in the context of patient decision support and to discuss implications for decision aid (DA) design.Methods
Conceptual review of the strengths and weaknesses of intuitive and analytical decision making and applying these findings to the practice of DA design.Results
DAs combine several important goals: providing information, helping to clarify treatment related values, supporting preference construction processes, and facilitating more active engagement in decision making. Many DAs encourage patients to approach a decision analytically, without solid theoretical or empirical grounding for this approach. Existing research in other domains suggests that both intuition and deliberation may support decision making. We discuss implications for patient decision support and challenge researchers to determine when combining these processes leads to better outcomes.Conclusions
Intuitive and analytical decision processes may have complementary effects in achieving the desired outcomes of patient decision support.Practice implications
DA developers should be aware that tools solely targeted at supporting deliberation may limit DA effectiveness and harm preference construction processes. Patients may be better served by combined strategies that draw on the strengths and minimize the weaknesses of both deliberative and intuitive processes. 相似文献62.
Andy Wing Chun Pang Ohsuke Migita Jeffrey R. MacDonald Lars Feuk Stephen W. Scherer 《Human mutation》2013,34(2):345-354
Even with significant advances in technology, few studies of structural variation have yet resolved to the level of the precise nucleotide junction. We examined the sequence of 408,532 gains, 383,804 losses, and 166 inversions from the first sequenced personal genome, to quantify the relative proportion of mutational mechanisms. Among small variants (<1 kb), we observed that 72.6% of them were associated with nonhomologous processes and 24.9% with microsatellites events. Medium‐size variants (<10 kb) were commonly related to minisatellites (25.8%) and retrotransposons (24%), whereas 46.2% of large variants (>10 kb) were associated with nonallelic homologous recombination. We genotyped eight new breakpoint‐resolved inversions at (3q26.1, Xp11.22, 7q11.22, 16q23.1, 4q22.1, 1q31.3, 6q27, and 16q24.1) in human populations to elucidate the structure of these presumed benign variants. Three of these inversions (3q26.1, 7q11.22, and 16q23.1) were accompanied by unexpected complex rearrangements. In particular, the 16q23.1 inversion and an accompanying deletion would create conjoined chymotrypsinogen genes (CTRB1 and CTRB2), disrupt their gene structure, and exhibit differentiated allelic frequencies among populations. Also, two loci (Xp11.3 and 6q27) of potential reference assembly orientation errors were found. This study provides a thorough account of formation mechanisms for structural variants, and reveals a glimpse of the dynamic structure of inversions. 相似文献
63.
Angela Fagerlin Michael Pignone Purva Abhyankar Nananda Col Deb Feldman-Stewart Teresa Gavaruzzi Jennifer Kryworuchko Carrie A Levin Arwen H Pieterse Valerie Reyna Anne Stiggelbout Laura D Scherer Celia Wills Holly O Witteman 《BMC medical informatics and decision making》2013,13(Z2):S8
Background
Consensus guidelines have recommended that decision aids include a process for helping patients clarify their values. We sought to examine the theoretical and empirical evidence related to the use of values clarification methods in patient decision aids.Methods
Building on the International Patient Decision Aid Standards (IPDAS) Collaboration’s 2005 review of values clarification methods in decision aids, we convened a multi-disciplinary expert group to examine key definitions, decision-making process theories, and empirical evidence about the effects of values clarification methods in decision aids. To summarize the current state of theory and evidence about the role of values clarification methods in decision aids, we undertook a process of evidence review and summary.Results
Values clarification methods (VCMs) are best defined as methods to help patients think about the desirability of options or attributes of options within a specific decision context, in order to identify which option he/she prefers. Several decision making process theories were identified that can inform the design of values clarification methods, but no single “best” practice for how such methods should be constructed was determined. Our evidence review found that existing VCMs were used for a variety of different decisions, rarely referenced underlying theory for their design, but generally were well described in regard to their development process. Listing the pros and cons of a decision was the most common method used. The 13 trials that compared decision support with or without VCMs reached mixed results: some found that VCMs improved some decision-making processes, while others found no effect.Conclusions
Values clarification methods may improve decision-making processes and potentially more distal outcomes. However, the small number of evaluations of VCMs and, where evaluations exist, the heterogeneity in outcome measures makes it difficult to determine their overall effectiveness or the specific characteristics that increase effectiveness.64.
65.
66.
JV Lodhia S Appiah P Tcherveniakov P Krysiak 《Annals of the Royal College of Surgeons of England》2015,97(2):e27-e29
Iatrogenic injury accounts for the second most common cause of acquired diaphragmatic hernias after penetrating trauma. An increased incidence of these hernias has been observed with the widespread use of laparoscopic surgery. We present the case of a 65-year-old woman who initially underwent sigmoid resection for an adenocarcinoma and a subsequent liver resection for metastasis. She was noted to have a left lower lobe pulmonary nodule on surveillance computed tomography, for which she underwent a mini-thoracotomy for a planned resection. At the time of surgery, the pulmonary nodule was discovered to be a diaphragmatic hernia, most probably of iatrogenic origin. We discuss the difficulty in diagnosis given her history and the location of such a lesion. 相似文献
67.
Is Implantation of a Left Ventricular Assist Device in Patients With Critical or Impending Cardiogenic Shock an Absolute Contraindication? Looking Back at Our Past Experience Trying to Identify Contraindicative Risk Factors
下载免费PDF全文
![点击此处可从《Artificial organs》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Angelo Maria Dell'Aquila Stefan R.B. Schneider Paolo Risso Henryk Welp David G. Glockner Sebastian Alles Jürgen R. Sindermann Mirela Scherer 《Artificial organs》2015,39(12):998-1004
Poor survival has been demonstrated after ventricular assist device (VAD) implantation for Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) profile 1 and 2 patients compared with more stable levels. However, risk factors within this high‐risk cohort have not been determined so far. The aim of the present study was to identify risk factors associated with this very high mortality rate. Between February 1993 and January 2013, 298 patients underwent VAD implantation in our institution. One hundred nine patients were in INTERMACS level 1 and 49 patients were in INTERMACS level 2 and were therefore defined as hemodynamically critical (overall 158 patients). Assist devices implanted were: HVAD HeartWare n = 18; Incor n = 11; VentrAssist n = 2; DeBakey n = 22; and pulsatile systems n = 105. After cumulative support duration of 815.35 months, Kaplan–Meier analysis revealed a survival of 63.9, 48.8, and 40.3% at 1, 6, and 12 months, respectively. Cox regression analyses identified age > 50 (P = 0.001, odds ratio [OR] 2.48), white blood cell count > 13.000/μL (P = 0.01, OR 2.06), preoperative renal replacement therapy (P = 0.001, OR 2.63), and postcardiotomy failure (P < 0.001, OR 2.79) as independent predictors of mortality. Of note, last generation VADs were not associated with significantly better 6‐month survival (P = 0.59). Patients without the aforementioned risk factors could yield a survival of 79.2% at 6 months. This single‐center experience shows that VAD implantation in hemodynamically unstable patients generally results in poor early outcome, even in third‐generation pumps. However, avoiding the aforementioned risk factors could result in improved outcome. 相似文献
68.
69.
Hermine A van Duyvenvoorde Julian C Lui Sarina G Kant Wilma Oostdijk Antoinet CJ Gijsbers Mari?tte JV Hoffer Marcel Karperien Marie JE Walenkamp Cees Noordam Paul G Voorhoeve Verónica Mericq Alberto M Pereira Hedi L Claahsen-van de Grinten Sandy A van Gool Martijn H Breuning Monique Losekoot Jeffrey Baron Claudia AL Ruivenkamp Jan M Wit 《European journal of human genetics : EJHG》2014,22(5):602-609
Height is a highly heritable and classic polygenic trait. Recent genome-wide association studies (GWAS) have revealed that at least 180 genetic variants influence adult height. However, these variants explain only about 10% of the phenotypic variation in height. Genetic analysis of short individuals can lead to the discovery of novel rare gene defects with a large effect on growth. In an effort to identify novel genes associated with short stature, genome-wide analysis for copy number variants (CNVs), using single-nucleotide polymorphism arrays, in 162 patients (149 families) with short stature was performed. Segregation analysis was performed if possible, and genes in CNVs were compared with information from GWAS, gene expression in rodents'' growth plates and published information. CNVs were detected in 40 families. In six families, a known cause of short stature was found (SHOX deletion or duplication, IGF1R deletion), in two combined with a de novo potentially pathogenic CNV. Thirty-three families had one or more potentially pathogenic CNVs (n=40). In 24 of these families, segregation analysis could be performed, identifying three de novo CNVs and nine CNVs segregating with short stature. Four were located near loci associated with height in GWAS (ADAMTS17, TULP4, PRKG2/BMP3 and PAPPA). Besides six CNVs known to be causative for short stature, 40 CNVs with possible pathogenicity were identified. Segregation studies and bioinformatics analysis suggested various potential candidate genes. 相似文献
70.
A CGG‐Repeat Expansion Mutation in ZNF713 Causes FRA7A: Association with Autistic Spectrum Disorder in Two Families
下载免费PDF全文
![点击此处可从《Human mutation》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Sofie Metsu Jacqueline K. Rainger Kim Debacker Birgitta Bernhard Liesbeth Rooms Daria Grafodatskaya Rosanna Weksberg Eric Fombonne Martin S. Taylor Stephen W. Scherer R. Frank Kooy David R. FitzPatrick 《Human mutation》2014,35(11):1295-1300
We report de novo occurrence of the 7p11.2 folate‐sensitive fragile site FRA7A in a male with an autistic spectrum disorder (ASD) due to a CGG‐repeat expansion mutation (~450 repeats) in a 5′ intron of ZNF713. This expanded allele showed hypermethylation of the adjacent CpG island with reduced ZNF713 expression observed in a proband‐derived lymphoblastoid cell line (LCL). His unaffected mother carried an unmethylated premutation (85 repeats). This CGG‐repeat showed length polymorphism in control samples (five to 22 repeats). In a second unrelated family, three siblings with ASD and their unaffected father were found to carry FRA7A premutations, which were partially or mosaically methylated. In one of the affected siblings, mitotic instability of the premutation was observed. ZNF713 expression in LCLs in this family was increased in three of these four premutation carriers. A firm link cannot yet be established between ASD and the repeat expansion mutation but plausible pathogenic mechanisms are discussed. 相似文献